These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8393549)

  • 21. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
    Huang JS; Luo X; Yu JX; Liu W; Chen XW; Xie L; Zhu XY; Chen GY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):408-11. PubMed ID: 17631708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet.
    Brar P; Kwon GY; Holleran S; Bai D; Tall AR; Ramakrishnan R; Green PH
    Am J Med; 2006 Sep; 119(9):786-90. PubMed ID: 16945614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
    Deepa PR; Varalakshmi P
    Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.
    Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F
    Nephron; 2002; 92(3):589-600. PubMed ID: 12372942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different types of heparin in haemodialysis: long-term effects on post-heparin lipases.
    Arnadottir M; Kurkus J; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1994 Nov; 54(7):515-21. PubMed ID: 7863228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
    Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
    Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis.
    Lai KN; Ho K; Cheung RC; Lit LC; Lee SK; Fung KS; Tong MK; Lam CW
    Int J Artif Organs; 2001 Jul; 24(7):447-55. PubMed ID: 11510916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population.
    Abo-Zenah H; Sabry A; Farouk A; Abdelhalim N; El-Sayed K; Sobh M
    Int Urol Nephrol; 2007; 39(2):609-18. PubMed ID: 17279435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients.
    Elisaf MS; Germanos NP; Bairaktari HT; Pappas MB; Koulouridis EI; Siamopoulos KC
    Am J Nephrol; 1997; 17(2):153-7. PubMed ID: 9096446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis.
    Akiba T; Tachibana K; Ozawa K; Chida Y; Ogasawara H; Yoshiyama N; Hoshino M; Inada T; Marumo F
    ASAIO J; 1992; 38(3):M326-30. PubMed ID: 1333845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
    Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
    Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced lipid concentrations during four years of dialysis with low molecular weight heparin.
    Deuber HJ; Schulz W
    Kidney Int; 1991 Sep; 40(3):496-500. PubMed ID: 1664903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase disturbances induced by uremia and hemodialysis.
    Stegmayr B; Olivecrona T; Olivecrona G
    Semin Dial; 2009; 22(4):442-4. PubMed ID: 19708998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.